BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3662541)

  • 1. Effects of crosslinking on the thermal stability of hemoglobin. I. The use of bis(3,5-dibromosalicyl) fumarate.
    White FL; Olsen KW
    Arch Biochem Biophys; 1987 Oct; 258(1):51-7. PubMed ID: 3662541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of crosslinking by bis(3,5-dibromosalicyl) fumarate on the autoxidation of hemoglobin.
    Yang T; Olsen KW
    Biochem Biophys Res Commun; 1989 Sep; 163(2):733-8. PubMed ID: 2783118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal stability of hemoglobin crosslinked in the T-state by bis(3,5-dibromosalicyl) fumarate.
    Yang T; Olsen KW
    Biochem Biophys Res Commun; 1991 Jan; 174(2):518-23. PubMed ID: 1993051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of crosslinking on the thermal stability of hemoglobins. II. The stabilization of met-, cyanomet-, and carbonmonoxyhemoglobins A and S with bis(3,5-dibromosalicyl) fumarate.
    Yang T; Olsen KW
    Arch Biochem Biophys; 1988 Mar; 261(2):283-90. PubMed ID: 3355152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal stability and cross-linking of Hb New York [beta 113(G15)Val----Glu].
    Yang T; Olsen KW
    Hemoglobin; 1989; 13(2):147-56. PubMed ID: 2737909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modification of hemoglobin by a long crosslinking reagent: bis(3,5-dibromosalicyl) sebacate.
    Zhang Q; Olsen KW
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1463-70. PubMed ID: 7945292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diaspirins that cross-link beta chains of hemoglobin: bis(3,5-dibromosalicyl) succinate and bis(3,5-dibromosalicyl) fumarate.
    Walder JA; Zaugg RH; Walder RY; Steele JM; Klotz IM
    Biochemistry; 1979 Oct; 18(20):4265-70. PubMed ID: 486423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal stabilities of hemoglobins crosslinked with different length reagents.
    Huang H; Olsen KW
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):719-24. PubMed ID: 7994393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of cross-linked asymmetrical hybrid hemoglobins by double-headed aspirin.
    Kikugawa K; Adachi K; Kosugi H; Asakura T
    Hemoglobin; 1983; 7(6):533-53. PubMed ID: 6668187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative ligand binding of crosslinked hemoglobins at very high temperatures.
    Bellelli A; Ippoliti R; Brancaccio A; Lendaro E; Brunori M
    J Mol Biol; 1990 Jun; 213(4):571-4. PubMed ID: 2359113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features required for the reactivity and intracellular transport of bis(3,5-dibromosalicyl)fumarate and related anti-sickling compounds that modify hemoglobin S at the 2,3-diphosphoglycerate binding site.
    Chatterjee R; Iwai Y; Walder RY; Walder JA
    J Biol Chem; 1984 Dec; 259(23):14863-73. PubMed ID: 6501320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine hemoglobin as a potential source of hemoglobin-based oxygen carriers: crosslinking with bis(2,3-dibromosalycyl)fumarate.
    Fronticelli C; Sato T; Orth C; Bucci E
    Biochim Biophys Acta; 1986 Nov; 874(1):76-81. PubMed ID: 3768378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of human hemoglobin crosslinked by bis(3,5-dibromosalicyl) fumarate using mass spectrometric techniques.
    Yu Z; Friso G; Miranda JJ; Patel MJ; Lo-Tseng T; Moore EG; Burlingame AL
    Protein Sci; 1997 Dec; 6(12):2568-77. PubMed ID: 9416606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton nuclear magnetic resonance investigation of cross-linked asymmetrically modified hemoglobins: influence of the salt bridges on tertiary and quaternary structures of hemoglobin.
    Miura S; Ho C
    Biochemistry; 1984 May; 23(11):2492-9. PubMed ID: 6477880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectroelectrochemical study of hemoglobin A, alpha- and beta-fumarate crosslinked hemoglobins; implications to autoxidation reaction.
    Dragan SA; Olsen KW; Moore EG; Fitch A
    Bioelectrochemistry; 2008 Jun; 73(1):55-63. PubMed ID: 18515189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1----lysine 99 alpha 2).
    Chatterjee R; Welty EV; Walder RY; Pruitt SL; Rogers PH; Arnone A; Walder JA
    J Biol Chem; 1986 Jul; 261(21):9929-37. PubMed ID: 3090027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine hemoglobin pseudo-crosslinked with mono(3,5-dibromosalicyl)-fumarate.
    Fronticelli C; Bucci E; Razynska A; Sznajder J; Urbaitis B; Gryczynski Z
    Eur J Biochem; 1990 Oct; 193(2):331-6. PubMed ID: 2226456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen equilibrium properties of nickel(II)-iron(II) hybrid hemoglobins cross-linked between 82 beta 1 and 82 beta 2 lysyl residues by bis(3,5-dibromosalicyl)fumarate: determination of the first two-step microscopic Adair constants for human hemoglobin.
    Shibayama N; Imai K; Morimoto H; Saigo S
    Biochemistry; 1995 Apr; 34(14):4773-80. PubMed ID: 7718584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb) for viral inactivation--effect of crosslinking.
    Azari M; Catarello J; Burhop K; Camacho T; Ebeling A; Estep T; Guzder S; Krause K; Marshall T; Rohn K; Sarajari R; Boose JA; Gauvin G; Horner R; Lu B; Pearson L; Vacante D
    Artif Cells Blood Substit Immobil Biotechnol; 1997 Nov; 25(6):521-6. PubMed ID: 9352057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute.
    Snyder SR; Welty EV; Walder RY; Williams LA; Walder JA
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7280-4. PubMed ID: 3478694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.